Law360, New York (October 26, 2011, 9:02 PM ET) -- The U.S. Food and Drug Administration raised safety concerns Tuesday involving the clinical trial of a Medtronic Inc. catheter system designed to treat irregular heartbeats, noting that the number of patients who experienced serious side effects had exceeded the expected maximum.
In a memorandum prepared for a Thursday meeting of the agency's Circulatory System Devices Panel, the FDA expressed concerns about the risk-benefit profile and approvability of the Medtronic Cardiac Ablation System, intended to treat long-standing, persistent atrial fibrillation.
Atrial fibrillation, the most common type of...
Medtronic Catheter Side Effects Are Cause For Concern: US
To view the full article, take a free trial now.
